|

Clinical and Biological Correlates of Obsessive-Compulsive Disorder and Online Mindfulness-Based Cognitive Therapy

RECRUITINGN/ASponsored by IRCCS Centro San Giovanni di Dio Fatebenefratelli
Actively Recruiting
PhaseN/A
SponsorIRCCS Centro San Giovanni di Dio Fatebenefratelli
Started2026-08-26
Est. completion2028-05
Eligibility
Age18 Years – 45 Years
Healthy vol.Accepted

Summary

The study has two main objectives: (1) to evaluate the acceptability and feasibility of a specialized Mindfulness-Based Cognitive Therapy (MBCT) program for Obsessive-Compulsive Disorder (OCD), delivered via videoconference in a synchronous group format; and (2) to explore the associations between selected clinical and biological markers, OCD severity, and treatment response. This is an interventional study involving outpatients with a diagnosis of OCD recruited at two participating centers in Italy: IRCCS Fatebenefratelli in Brescia (Center 1) and Centro Terapia Cognitiva e Mindfulness per il DOC in Vicenza (Center 2). Participants will take part in group-based treatment based on the MBCT program for OCD. Participants recruited at Center 1 will undergo blood and saliva sampling for the molecular analyses planned as part of the study. A healthy control group, matched for age and sex, will also be recruited for comparison in the analyses related to the second objective.

Eligibility

Age: 18 Years – 45 YearsHealthy volunteers accepted
Patients with OCD.

Inclusion Criteria:

* Diagnosis of obsessive-compulsive disorder (OCD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
* Age between 18 and 45 years
* Stable pharmacological treatment for at least 3 months prior to the start of the experimental intervention
* No previous experience with mindfulness meditation, or previous mindfulness meditation experience with no practice during the 12 months prior to study enrollment
* Ability and willingness to provide written informed consent.

Exclusion Criteria:

* Diagnosis of schizophrenia spectrum or other psychotic disorders, including schizoaffective disorder
* Diagnosis of bipolar and related disorders
* Major depressive disorder in an acute phase
* Active substance use disorder or alcohol use disorder as the primary diagnosis
* Personality disorders of clinically significant severity
* Documented major neurocognitive disorder. Neurological conditions or medical conditions with a clinically significant impact on cognitive or mental functioning
* Previous mindfulness meditation practice within the 12 months prior to study enrollment
* Inability or unwillingness to provide informed consent

Healthy subjects.

Inclusion Criteria:

* Age between 18 and 45 years, with age matching within a maximum difference of ±3 years from the corresponding index patient. In all cases, control participants must be at least 18 years and no older than 48 years
* Voluntary participation in the study.
* Ability and willingness to provide written informed consent

Exclusion criteria:

* Age younger than 18 years
* History of psychiatric disorders, as assessed using the Structured Clinical Interview for DSM-5 Disorders - Clinician Version (SCID-CV)
* Intellectual developmental disorder.
* Current substance use disorder or alcohol use disorder
* Neurological disorders, including Parkinson's disease, major neurocognitive disorders, neurodegenerative syndromes, ataxias, multiple sclerosis, cerebrovascular events (stroke or transient ischemic attack \[TIA\]), central nervous system neoplasms, epilepsy, history of seizures, or clinically significant tremor
* Systemic medical conditions (e.g., diabetes mellitus, atherosclerosis, chronic arterial hypertension, or malignancies) requiring pharmacological treatment
* Current or previous mindfulness meditation practice within the 12 months prior to study enrollment

Conditions2

AnxietyObsessive-compulsive Disorder

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.